Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and.

Slides:



Advertisements
Similar presentations
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Serum Creatinine Is an Inadequate Screening Test.
Advertisements

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: The State of US Health, : Burden of Diseases,
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Fixed-Dose Combination Strategy on Adherence.
Date of download: 5/29/2016 From: The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow- up of the Modification.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aspirin for the Prevention of Cardiovascular Events.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Elective Intra-aortic Balloon Counterpulsation During.
Date of download: 6/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Bacterial Coinfection in Influenza: A Grand Rounds.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnoses and Timing of 30-Day Readmissions After.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Inflammatory Biomarkers and Exacerbations in Chronic.
Date of download: 6/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Calf Muscle Characteristics, Strength Measures, and.
Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid.
Date of download: 6/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Major Lipids, Apolipoproteins, and Risk of Vascular.
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Risk Stratification for In-Hospital Mortality in.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association Between Influenza Vaccination and Cardiovascular.
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Risk of End-Stage Renal Disease Following Live Kidney.
Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Pulse Pressure in Relation to Tau-Mediated Neurodegeneration,
Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Sickle Cell Trait With Chronic Kidney.
Date of download: 6/25/2016 From: Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study Ann Intern Med. 2013;159(4):
Date of download: 6/26/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Trends in Anemia Care in Older Patients Approaching.
Date of download: 6/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Urinary Sodium and Potassium Excretion and Risk of.
Date of download: 6/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cardiorespiratory Fitness as a Quantitative Predictor.
Date of download: 7/1/2016 From: Time-Updated Systolic Blood Pressure and the Progression of Chronic Kidney Disease: A Cohort Study Ann Intern Med. 2015;162(4):
Date of download: 7/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Fibroblast Growth Factor 23 and Risks of Mortality.
Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of High vs Low Glycemic Index of Dietary Carbohydrate.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Angiotensin-Converting Enzyme Inhibitor–Associated.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: The Relationship Between Magnitude of Proteinuria.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Projection of Diabetic Retinopathy and Other Major.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Glycated Hemoglobin Measurement and Prediction of.
Date of download: 11/12/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Independent Components of Chronic Kidney Disease.
Dr John Cox Diabetes in Primary Care Conference Cork
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Copyright © 2013 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2014 American Medical Association. All rights reserved.
From: Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney DiseaseA Secondary Analysis.
Copyright © 2006 American Medical Association. All rights reserved.
Copyright © 2015 American Medical Association. All rights reserved.
Copyright © 2010 American Medical Association. All rights reserved.
Copyright © 2003 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Copyright © 2004 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Copyright © 2000 American Medical Association. All rights reserved.
Copyright © 2006 American Medical Association. All rights reserved.
Copyright © 2004 American Medical Association. All rights reserved.
Ann Intern Med. 2013;159(6): doi: / Figure Legend:
Copyright © 2002 American Medical Association. All rights reserved.
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2013 American Medical Association. All rights reserved.
Copyright © 2003 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2009 American Medical Association. All rights reserved.
From: Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular DiseaseGrand Rounds Discussion From the Beth Israel Deaconess Medical.
Copyright © 2011 American Medical Association. All rights reserved.
From: Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate.
Copyright © 2012 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Associations of renal impairment (adjusted odds ratio and 95% CI) and the presence of individual small vessel disease markers stratified by age. Associations.
Volume 86, Issue 4, Pages (October 2014)
Volume 79, Issue 12, Pages (June 2011)
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Presentation transcript:

Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality JAMA. 2014;311(24): doi: /jama End-Stage Renal Disease (ESRD) Associated With Percentage Change in Estimated GFR During a 2-Year Baseline PeriodValues trimmed at less than −70% change (0.22% and 0.055% of the study population for estimated GFR <60 mL/min/1.73 m 2 and ≥60 mL/min/1.73 m 2, respectively) and greater than 40% change (5.9% and 0.51% of the population for estimated GFR <60 mL/min/1.73 m 2 and ≥60 mL/min/1.73 m 2, respectively). In the top 2 panels, the diamonds indicate the reference point of 0% change in estimated GFR. Figure Legend:

Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality JAMA. 2014;311(24): doi: /jama Risk of End-Stage Renal Disease by Change in Estimated Glomerular Filtration Rate (GFR) During a 2-Year Baseline Period, First Estimated GFR, and Subsequent Follow-upBaseline risk is calculated for participants with 0% change in estimated GFR, estimated GFR of 50 mL/min/1.73 m 2, age of 60 years, male sex, nonblack race, systolic blood pressure of 130 mm Hg, total cholesterol level of 5 mmol/L, and without diabetes or a history of cardiovascular disease. Figure Legend:

Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality JAMA. 2014;311(24): doi: /jama All-Cause Mortality Associated With Percentage Change in Estimated GFR During a 2-Year Baseline PeriodValues trimmed at less than −70% change (0.30% and 0.050% of the study population for estimated GFR <60 mL/min/1.73 m 2 and ≥60 mL/min/1.73 m 2, respectively) and greater than 40% change (5.8% and 0.46% of the population for estimated GFR <60 mL/min/1.73 m 2 and ≥60 mL/min/1.73 m 2, respectively). In the top 2 panels, the diamonds indicate the reference point of 0% change in estimated GFR. Figure Legend:

Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality JAMA. 2014;311(24): doi: /jama Risk of All-Cause Mortality by Change in Estimated Glomerular Filtration Rate (GFR) During a 2-Year Baseline Period, First Estimated GFR, and Subsequent Follow-upBaseline risk is calculated for participants with 0% change in estimated GFR, estimated GFR of 50 mL/min/1.73 m 2, age of 60 years, male sex, nonblack race, systolic blood pressure of 130 mm Hg, total cholesterol level of 5 mmol/L, and without diabetes or a history of cardiovascular disease. Figure Legend: